Skip to ContentSkip to Navigation
founded in 1614  -  top 100 university
Sluiten
Over ons Praktische zaken Waar vindt u ons prof. dr. G.H. (Truuske) de Bock
University Medical Center Groningen

prof. dr. G.H. (Truuske) de Bock

Hoogleraar oncologische epidemiology
Research interests Publicaties Pers/media

Research interests

The research of Geertruida de Bock is about the early detection of cancer and improvement of outcomes after cancer treatment. To evaluate this in a systematic way, she set up an UMCG’s oncology databiobank OncoLifeS with quality of life as a main outcome. To assess and optimize screening strategies, she works on defining which populations are at risk of cancer and negative outcomes. She does not only consider benefits of screening and treatment, but also the negative effects of over-diagnosis, tumor-induction, false-positive results, and side-effects. Systematic literature reviews, analysis of cohorts and modelling are the most important methods she uses.

Publicaties

Artificial intelligence as an independent reader of risk-dominant lung nodules: influence of CT reconstruction parameters

Mao, Y., Heuvelmans, M. A., van Tuinen, M., Yu, D., Yi, J., Oudkerk, M., Ye, Z., de Bock, G. H. & Dorrius, M. D., mrt.-2026, In: European Radiology. 36, blz. 2014 - 2023 10 blz.

Onderzoeksoutput › › peer review

Corrigendum to "Regional differences in predictive biomarker testing rates for patients with metastatic NSCLC in the Netherlands" [Eur J Cancer 205 (2024)114125]

de Jager, V. D., Cajiao Garcia, B. N., Kuijpers, C. C. H. J., de Bock, G. H., Maas, W. J., Timens, W., van Kempen, L. C., van der Wekken, A. J., Schuuring, E. & Willems, S. M., 26-mrt.-2026, In: European Journal of Cancer. 237, 116597.

Onderzoeksoutput

Impact of screening on late-stage breast cancer in the Netherlands: a population-based cohort study (2007-2016)

Lin, Y., Sidorenkov, G., Wang, J., Greuter, M. J. W., Houssami, N., Dorrius, M. D., Siesling, S., de Munck, L. & de Bock, G. H., 2-mrt.-2026, (E-pub ahead of print) In: The Breast. 86, blz. 104745

Onderzoeksoutput › › peer review

Improving Lung Cancer Screening Selection: A Comparative Analysis of Risk Models and Traditional Criteria in a Western European General Population

Zhong, D., Sidorenkov, G., Greuter, M. J. W., Jacobs, C., de Jong, P. A., Gietema, H. A., Groen, H. J. M., Mohamed Hoesein, F. A. A., Antonissen, N., Stadhouders, R., Lancaster, H. L., Heuvelmans, M. A., Vliegenthart, R. & de Bock, G. H., 24-feb.-2026, In: Cancers. 18, 5

Onderzoeksoutput › › peer review

Influence of follow-up, screening age, interval, and compliance on overdiagnosis of ductal carcinoma in situ (DCIS): A modelling study

Poelhekken, K., Greuter, M. J. W., Dorrius, M. D. & de Bock, G. H., jan.-2026, In: PLoS ONE. 21, 1, 10 blz., e0331821.

Onderzoeksoutput › › peer review

Integrated geriatric assessment and intervention in the head and neck oncology care pathway reduces adverse events and does not affect survival

Padovan, B. V., Beenker, M., Langendijk, J. A., van der Laan, H. P., van Dijk, B. A. C., de Bock, G. H., Plaat, B. E. C., de Graeff, P., Festen, S. & Halmos, G. B., jan.-2026, In: Oral Oncology. 172, 7 blz., 107811.

Onderzoeksoutput › › peer review

Nutritional prehabilitation in head and neck cancer patients (PreHead) – A randomized controlled trial study protocol

Sijbrands, D., Gort-Van Dijk, D., de Visscher, S. A. H. J., van der Hoorn, A., Steenbakkers, R. J. H. M., Jager-Wittenaar, H., de Bock, G. H., Zwart, A. T., Halmos, G. B. & Wegner, I., apr.-2026, In: PLoS ONE. 21, 4, 13 blz., e0346273.

Onderzoeksoutput › › peer review

Outcomes for ER-positive CHEK2 c.1100delC breast cancer patients compared with breast cancer patients without the variant

HEBON, Schreurs, M. A. C., Adank, M. A., Heemskerk-Gerritsen, B. A. M., Hollestelle, A., Smallenbroek, N., van Asperen, C. J., Ausems, M. G. E. M., van de Beek, I., de Bock, G. H., Boere, I., van Hest, L. P., van Kaam, K. J. A. F., de Munck, L., Vos, J. R., Jager, A., Schmidt, M. K. & Hooning, M. J., feb.-2026, In: Breast. 85, 8 blz., 104666.

Onderzoeksoutput › › peer review

Prevalence of cardiac dysfunction and longitudinal changes in cardiac function after breast cancer treatment with chemotherapy with/without radiation therapy compared with controls

van der Wal, L. T., Maass, S. W. M. C., de Boer, M. R., Blanker, M. H., Crijns, A. P. G., Gietema, J. A., van der Meer, P., de Bock, G. H. & Brandenbarg, D., jun.-2026, In: Breast. 87, 8 blz., 104781.

Onderzoeksoutput › › peer review

Programmed Death Ligand-1 Testing in Triple-Negative Breast Cancer: National Practice and Interlaboratory Variation in the Netherlands

Dekker, M., Hempenius, M. A., de Bock, G. H., van Kruchten, M., van Vugt, M. A. T. M., Siebers, A. G. & van der Vegt, B., mei-2026, In: Laboratory Investigation. 106, 5, 9 blz., 106121.

Onderzoeksoutput › › peer review

Pers/media

Mannen krijgen vaker kankertherapie die de tumor aanpakt dan vrouwen

de Bock, T.

20/11/2023

Pers / media: Expert Comment ›

Mannen krijgen vaker kankertherapie die de tumor aanpakt dan vrouwen

de Bock, G.

20/11/2023

Pers / media: Expert Comment ›

Steeds meer mensen met kanker

de Bock, T.

06/05/2022

Pers / media: Expert Comment ›

Steeds meer mensen met kanker: 'Zien nu effecten van veel roken en zonnen'

de Bock, T.

04/05/2022

Pers / media: Expert Comment ›

UMCG krijgt vier ton subsidie voor verbetering onderzoek naar baarmoederhalskanker.

Schuurs-Wisman, B., Schuuring, E. & Bock, de, T.

27/06/2019

Pers / media: Onderzoek ›

Bekijk volledig onderzoeksprofiel
Volg de RUG
Stel je cookievoorkeur in. Lees onze privacy en cookie disclaimer voor meer informatie.